
Biotech Stock Vera Is Slumping After Monster Gain
Vera Therapeutics stock rocketed nearly 70% on Monday on upbeat data for a kidney-disease trial. Shares are tumbling Friday on a rival’s study. Continue Reading View Comments
- June 06, 2025 08:02 AM PDT
- EODHD